Rueil-Malmaison, France

Charles W Roth

USPTO Granted Patents = 4 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Rueil Malaison, FR (2006)
  • Rueil-Malmaison, FR (2005 - 2012)

Company Filing History:


Years Active: 2005-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovations of Charles W Roth

Introduction

Charles W Roth is a notable inventor based in Rueil-Malmaison, France. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines against malaria. With a total of 4 patents, Roth's work has had a considerable impact on medical research and public health.

Latest Patents

Roth's latest patents include a purified polypeptide that comprises a C-terminus Merozoite Surface Protein 1 (MSP1) antigen, which carries a Glycosyl-phosphatidyl-inositol group (GPI). This invention is crucial for creating an immunogenic composition and a vaccine against malaria. Another significant patent involves a recombinant protein fabricated in a baculovirus system, which features a C-terminal fragment of 19 kilodalton (p19) of the surface protein 1 (MSP-1) of the merozoite parasite. This protein is essential for the production of vaccines aimed at combating malaria.

Career Highlights

Throughout his career, Charles W Roth has worked with prestigious institutions such as Institut Pasteur and New York University. His research has focused on developing innovative solutions to combat infectious diseases, particularly malaria.

Collaborations

Roth has collaborated with notable colleagues, including Faridabano Nato and Shirley Longacre-Andre. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Charles W Roth's contributions to the field of biotechnology and vaccine development are noteworthy. His innovative patents and collaborations highlight his commitment to improving public health through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…